Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $41.69 USD
Change Today +0.02 / 0.05%
Volume 433.9K
ACAD On Other Exchanges
Symbol
Exchange
NASDAQ GS
Stuttgart
As of 8:10 PM 07/2/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Uli Hacksell Ph.D.

Former Chief Executive Officer, President and Director, ACADIA Pharmaceuticals Inc.
AgeTotal Calculated CompensationThis person is connected to 33 board members in 4 different organizations across 6 different industries.

See Board Relationships
65$5,877,502
As of Fiscal Year 2014

Background*

Dr. Uli Hacksell, Ph.D. served as the Chief Executive Officer of ACADIA Pharmaceuticals Inc. from September 2000 to March 11, 2015 and served as its President until March 11, 2015. Dr. Hacksell served as the Chief Financial Officer and Chief Accounting Officer of ACADIA Pharmaceuticals Inc., from April 18, 2014 to July 2014. He served as an Executive Vice President of Drug Discovery from February 1999 to September 2000. From August 1991 to February 1999, Dr. Hacksell ...

Read Full Background

Corporate Headquarters*

3611 Valley Centre Drive
San Diego, California 92130

United States

Phone: 858-558-2871
Fax: 858-558-2872

Board Members Memberships*

Director
2000-2015
Former Chief Executive Officer, President and Director
2000-N/A
Former Chairman
2015-Present
Director
2015-Present
Chairman of The Board
2015-Present
Chairman

Education*

PhD 1981
Uppsala Universitet
Master's Degree 1976
Uppsala Universitet

Other Affiliations*

Annual Compensation*

Salary$580,000
Bonus$208,800
Total Annual Compensation$788,800

Stock Options*

All Other Compensation$13,977
Exercised Options250,000
Exercised Options Value$5,112,400
Exercisable Options1,088,500
Unexercisable Options550,000
Total Value of Options$5,112,400
Total Number of Options1,888,500

Total Compensation*

Total Annual Cash Compensation$802,777
Total Short Term Compensation$788,800
Other Long Term Compensation$13,977
Total Calculated Compensation$5,877,502
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ACAD:US $41.69 USD +0.02

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Ron Cohen M.D.Founder, Chief Executive Officer, President and Director
Acorda Therapeutics, Inc.
$745.8K
Stanley T. Crooke M.D., Ph.D.Founder, Executive Chairman, Chief Executive Officer, President, Chairman of Science/Medical Committee and Member of Agenda Committee
Isis Pharmaceuticals, Inc.
$1.5M
James A. Schoeneck Chief Executive Officer, President and Director
DepoMed Inc.
$620.1K
George Frederick Wilkinson Chief Executive Officer, President and Director
Impax Laboratories Inc.
$552.5K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ACADIA PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.